Module 6: Allergy and URI Flashcards
1st Generation antihistamines example
Benadryl, promethazine (phenergen)
Indication for Bendryl
Flu, cold, and allergy symptoms Insomnia Anaphylaxis Motion sickness Parkinsonism Pruritus Anxiety
MOA benedryl
Acts as an antihistamine by competing with histamine for receptor sites on effector cells.
Block both histaminic and muscarinic receptors as well as passing the blood-brain barrier
Safety Benedryl
SEDATION
Anticholinergic effects
Use with or within 14 days of MAO inhibitor therapy
To sedate a child
Do not use: Newborns, premature infants, nursing mothers
Caution about sedative effects and use caution in using in the elderly
D2D: CYP2D6 inhibitor, weak, anticholinergic effects, CNS depression, decrease central histamine effects
BBW Promethazine (phenergan)
in children less than two years old: serious behavioral and other adverse effects
Education with benedryl
Avoid concomitant use of MAO inhibitors or CNS depressants.
No alcohol
Avoid applying occlusive dressings, cosmetics, or other skin products over areas treated with topical formulation.
Patient should not use topical form on eyes or eyelid.
Pediatric considerations Benedryl
Cr at baseline (peds)
Young children may experience a paradoxical excitation effect.
2nd Generation antihistamines example
*cetirizine (Zyrtec)
**Fexofenadine (Allegra)
Indication Zyrtec and Allegra
Allergic rhinitis Sneezing Itchy/watery eyes Itchy nose/throat Chronic idiopathic urticaria
MOA zyrtec and allegra
Acts as an antihistamine by competing with histamine for receptor sites on effector cells.
Blocks histaminic receptors and does not pass the blood-brain barrier
Caution with zyrtec and allegra
Caution in patients 65 yo and older
*Caution if concurrent CNS depressant use
Cr at baseline, then in elderly pts consider periodically
D2d with allegra and zyrtec
Zyrtec safety
Sedating, CNS depression, decreases central histamine effects
Safety allegra
prolonged Qt, OATP1A2 substrate, OATP2B1 substrate, P-gp substrate, binds to polyvalent cations
Nasal Decongestants example
Oxymetazoline (Afrin)
Afrin indication
Nasal congestion, sinus congestion/pressure
MOA afrin
Stimulates smooth muscle alpha adrenergic receptors, producing vasoconstriction and reducing nasal congestion
Safety afrin
MAO inhibitor use within 14 days
Caution in individuals with glaucoma, angle-closure, HTN, cardiovascular disease, diabetes, hyperthyroidism
D2D: hypertensive effects, interferes with radiolabeled norepinephrine analog effect
Special considerations/education afrin
No routine tests recommended
Rebound congestion
Use for 3 days or less
Oral decongestants example
Sudafed
Indication Sudafed
Nasal congestion due to common cold, hay fever, or upper respiratory allergies
MOA sudafed
Enhance norepinephrine and epinephrine or adrenergic activity by stimulating the alpha1-adrenergic receptor which induces vasoconstriction.
Caution and D2D Sudafed
Anticholenergic
Caution: pregnancy
Caution in individuals with glaucoma, angle-closure, HTN, cardiovascular disease, diabetes, hyperthyroidism
D2D: (alpha-1 agonist; beta-2 agonist) hyperglycemic effects, hypertensive effects, interferes with radiolabeled norepinephrine analog effect, urine pH sensitivity.
Sudafed in children
Use in pediatric patients <4 years of age has limited efficacy, the AAP warns against the use in young children.
Antitussives example
Tessalon Perles
Benzonatate
Indication tessalon pearls and Benzontate
Cough suppressant
MOA Tessalon pearls and benzonatate
Anesthetizes respiratory passage, lung, and pleural stretch receptors, reducing cough reflex
Safety antitussives
Hypersensitivity can cause bronchospasm and laryngospasm
May cause bizarre behavior (confusion, visual hallucinations)
May cause sedation
Expectorants example
Mucinex
guaifenesin
Indication Mucinex and guaifenesin
Help loosen mucus and thin bronchial secretions
MOA mucinex and guaifenesin
Increases volume and decreases viscosity of respiratory tract secretions
Safety Mucinex and guaifenesin
Caution in nephrolithiasis
Caution in patients <6 yo
D2D: None
Intranasal Antihistamines examples
Astelin (azelastine)
Olopatadine
Astelin (azelastine)
Olopatadine
Indication
Perennial allergic rhinitis
Seasonal allergic rhinitis
Vasomotor rhinitis
MOA Astelin (azelastine) and Olopatadine
Antagonizes central and peripheral histamine H1 receptors
Inhibits histamine release from mast cells
Safety Astelin (azelastine) and Olopatadine
Caution if concurrent CNS depressant use Caution if depression history must be >6 yo D2D: None May cause nasal septal perforation, nasal ulcer, hyposmia, anosmia, depression in long-term use
Leukotriene Modifiers/Blockers
Montelukast (Singular)
zafirlukast (Accolate)
Indication Montelukast (Singular) and zafirlukast (Accolate)
Allergic rhinitis
Asthma
Bronchoconstriction
MOA Montelukast (Singular) and zafirlukast (Accolate)
Selectively binds to cysteinyl leukotriene receptors
Safety Montelukast (Singular) and zafirlukast (Accolate)
Caution severe asthma
Caution if PKU
D2D: CYP2C8 substrate, CYP2C9 substrate, CYP3A4 substrate
Monitor s/sx neuropsychiatric events incl. depression, behavior changes, sleep disturbances, suicidality
Can cause suicidality, aggressive behavior, hallucinations, depression
Can cause pulmonary eosinophilia
Can cause hepatic failure
Can cause Churg-Strauss syndrome
BBW Montelukast (Singular) and zafirlukast (Accolate)
Neuropsychiatric events
Nasal Corticosteroids example
Flonase (fluticasone)
Flonase indication
Allergic rhinitis Asthma Bronchoconstriction Allergic rhinitis Nasal polyps Nonallergic rhinitis
MOA flonase
Exact mechanism unknown; inhibits multiple inflammatory cytokines; produces multiple glucocorticoid and mineralocorticoid effects
Safety and D2D flonase
Unhealed nasal septal ulcer or wound
Caution if hepatic impairment, recent long-term systemic corticosteroid, glaucoma, cataracts
D2D: CYP3A4 substrate, immunosuppressive effects
What can be suppressed with long term use of Flonase
Can cause growth suppression (long-term use in peds patients) Adrenal suppression (long-term use)
Intranasal Cromolyn example
NasalCrom
Indication NasalCrom
Allergic rhinitis
MOA NasalCrom
Inhibits mast cell degranulation (mast cell stabilizer)
Safety NasalCrom
Can cause bronchospasm, nasal burning, sneezing
Optic decongestant/antihistamine example
Naphazoline/pheniramine (Naphcon-A, Opcon-A)
Naphazoline/pheniramine (Naphcon-A, Opcon-A) Indication
Decrease eye redness
Naphazoline/pheniramine (Naphcon-A, Opcon-A) MOA
Binds to histamine 1 receptors, thereby inhibiting phospholipase A2 and production of endothelium-derived relaxing factor
Caution and D2D Naphazoline/pheniramine (Naphcon-A, Opcon-A)
Caution: individuals with diabetes, glaucoma, heart problems, HTN, hyperthyroidism, eye infection/injury
D2D: Hypertensive effects, interferes with radiolabeled norephinephrine analog effect
Side effects Naphazoline/pheniramine (Naphcon-A, Opcon-A)
Can cause dilated pupils, blurred vision
Can cause worsening eye redness, itching swelling, eye pain